|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dieterich M, Stubert J, Reimer T, Erickson
N and Berling A: Influence of lifestyle factors on breast cancer
risk. Breast Care. 9:407–414. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Seltenrich N: Institutes in the Lead:
Identifying environmental factors in breast cancer. Environ Health
Perspect. 124:A199–A205. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rennó AL, Alves-Júnior MJ, Rocha RM, De
Souza PC, de Souza VB, Jampietro J, Vassallo J, Hyslop S, Anhê GF,
de Moraes Schenka NG, et al: Decreased expression of stem cell
markers by simvastatin in 7,12-dimethylbenz(a)anthracene
(DMBA)-induced breast cancer. Toxicol Pathol. 43:400–410. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Russo J: Significance of rat mammary
tumors for human risk assessment. Toxicol Pathol. 43:145–170. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Al-Dhaheri WS, Hassouna I, Al-Salam S and
Karam SM: Characterization of breast cancer progression in the rat.
Ann NY Acad Sci. 1138:121–131. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ciriello G, Miller ML, Aksoy BA,
Senbabaoglu Y, Schultz N and Sander C: Emerging landscape of
oncogenic signatures across human cancers. Nat Genet. 45:1127–1133.
2013. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Peng L, Xu T, Long T and Zuo H:
Association between BRCA status and P53 status in breast cancer: A
meta-analysis. Med Sci Monit. 22:1939–1945. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rivlin N, Brosh R, Oren M and Rotter V:
Mutations in the p53 tumor suppressor gene: Important milestones at
the various steps of tumorigenesis. Genes Cancer. 2:466–474. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Elledge RM and Allred DC: The P53 tumor
suppressor gene in breast cancer. Breast Cancer Res Treat.
32:39–47. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Maslon MM and Hupp TR: Drug discovery and
mutant p53. Trends Cell Biol. 20:542–555. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jiang Q and Greenberg RA: Deciphering the
BRCA1 tumor suppressor network. J Biol Chem. 290:17724–17732. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rosen EM, Fan S, Pestell RG and Goldberg
ID: BRCA1 gene in breast cancer. J Cell Physiol. 196:19–41.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Miki Y, Swensen J, Shattuck-Eidens D,
Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM,
Ding W, et al: A strong candidate for the breast and ovarian cancer
susceptibility gene BRCA1. Science. 266:66–71. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Easton DF, Bishop DT, Ford D and Crockford
GP: Genetic linkage analysis in familial breast and ovarian cancer:
Results from 214 families. The breast cancer linkage consortium. Am
J Hum Genet. 52:678–701. 1993.PubMed/NCBI
|
|
16
|
Keshavarzi F, Javadi GR and Zeinali S:
BRCA1 and BRCA2 germline mutations in 85 Iranian
breast cancer patients. Fam Cancer. 11:57–67. 2011. View Article : Google Scholar
|
|
17
|
Shen SX, Weaver Z, Xu X, Li C, Weinstein
M, Chen L, Guan XY, Ried T and Deng CX: A targeted disruption of
the murine Brca1 gene causes gamma-irradiation
hypersensitivity and genetic instability. Oncogene. 17:3115–3124.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ottini L, D'Amico C, Noviello C, Lauro S,
Lalle M, Fornarini G, Colantuoni OA, Pizzi C, Cortesi E, Carlini S,
et al: BRCA1 and BRCA2 mutations in central and
southern Italian patients. Breast Cancer Res. 2:307–310. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fraser JA, Reeves JR, Stanton PD, Black
DM, Going JJ, Cooke TG and Bartlett JM: A role for BRCA1 in
sporadic breast cancer. Br J Cancer. 88:1263–1270. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Feng Z, Kachnic L, Zhang J, Powell SN and
Xia F: DNA damage induces p53-dependent BRCA1 nuclear export. J
Biol Chem. 279:28574–28584. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang ES and Xia F: BRCA1 16 years later:
DNA damage-induced BRCA1 shuttling. FEBS J. 277:3079–3085. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hollstein M, Sidransky D, Vogelstein B and
Harris CC: p53 mutation in human cancers. Science. 253:49–53. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zurer I, Hofseth LJ, Cohen Y, Xu-Welliver
M, Hussain SP, Harris CC and Rotter V: The role of p53 in base
excision repair following genotoxic stress. Carcinogenesis.
25:11–19. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gannon JV, Greaves R, Iggo R and Lane DP:
Activating mutation in p53 produce a common conformational effect.
A monoclonal antibody specific for the mutant form. EMBO J.
9:1595–1602. 1990.PubMed/NCBI
|
|
25
|
Andersen TI, Holm R, Nesland JM, Heimdal
KR, Ottestad L and Børresen AL: Prognostic significance of TP53
alterations in breast carcinoma. Br J Cancer. 68:540–548. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lee CH, Kim WH, Lim JH, Kang MS, Kim DY
and Kweon OK: Mutation and overexpression of p53 as a prognostic
factor in canine mammary tumors. J Vet Sci. 5:63–69. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Rossner P Jr, Gammon MD, Zhang YJ, Terry
MB, Hibshoosh H, Memeo L, Mansukhani M, Long CM, Garbowski G,
Agrawal M, et al: Mutations in p53, p53 protein
overexpression and breast cancer survival. J Cell Mol Med.
13:3847–3857. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kalemi TG, Lambropoulos AF, Gueorguiev M,
Chrisafi S, Papazisis KT and Kotsis A: The association of p53
mutations and p53 codon 72, Her 2 codon 655 and MTHFR C677T
polymorphisms with breast cancer in Northern Greece. Cancer Lett.
222:57–65. 2004. View Article : Google Scholar
|
|
29
|
Jerry DJ, Kittrell FS, Kuperwasser C,
Laucirica R, Dickinson ES, Bonilla PJ, Butel JS and Medina DA:
Mammary-specific model demonstrates the role of the p53 tumor
suppressor gene in tumor development. Oncogene. 19:1052–1058. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Malisic E, Jankovic R, Slavkovic D,
Milovic-Kovacevic M and Radulovic S: P53 gene mutations and codon
72 polymorphism in ovarian carcinoma patients from Serbia. J BUON.
15:101–106. 2010.PubMed/NCBI
|
|
31
|
Keohavong P, Gao WM, Mady HH,
Kanbour-Shakir A and Melhem MF: Analysis of p53 mutations in cells
taken from paraffin-embedded tissue sections of ductal carcinoma in
situ and atypical ductal hyperplasia of the breast. Cancer Lett.
212:121–130. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhou W, Muggerud AA, Vu P, Due EU, Sørlie
T, Børresen-Dale AL, Wärnberg F and Langerød A: Full sequencing of
TP53 identifies identical mutations within in situ and invasive
components in breast cancer suggesting clonal evolution. Mol Oncol.
3:214–219. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Jerry DJ, Ozbun MA, Kittrell FS, Lane DP,
Medina D and Butel JS: Mutations in p53 are frequent in the
preneolpastic stage of mouse mammary tumor development. Cancer Res.
53:3374–3381. 1993.PubMed/NCBI
|
|
34
|
Manjanatha MG, Chen JB, Shaddock JG Jr,
Harris AJ, Shelton SD and Casciano DA: Molecular analysis of
lacI mutations in Rat2™ cells exposed to
7,12-dimethylbenz[a]anthracene: Evidence for DNA sequence
and DNA strand biases for mutation. Mutat Res. 372:53–64. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chatterjee M, Janarthan M, Manivannan R,
Rana A and Chatterjee M: Combinatorial effect of fish oil (Maxepa)
and 1α,25-dihydroxyvitamin D3 in the chemoprevention of
DMBA-induced mammary carcinogenesis in rats. Chem Biol Interact.
188:102–110. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chakravarti D, Pelling JC, Cavalieri EL
and Rogan EG: Relating aromatic hydrocarbon-induced DNA adducts and
c-H-ras mutations in mouse skin papillomas: The role of
apurinic sites. Proc Natl Acad Sci USA. 92:10422–10426. 1995.
View Article : Google Scholar : PubMed/NCBI
|
